Latest Stem Cell News

Canadian research team makes safe iPS cells by the millionsUniversity of Calgary researchers Derrick Rancourt, PhD, and Roman Krawetz, PhD, have perfected a new bioreactor technology that allows them to make millions of pluripotent stem cells much more quickly than ever before. “The even better news is, we...

Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoire

Parameters predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma

Stem-cell transplants help some with Richter's syndromeNEW YORK (Reuters Health) - Autologous or allogeneic stem-cell transplants (SCT) were effective consolidation therapies for some patients with Richter's syndrome (transformed chronic lymphocytic leukemia) in a retrospective study from Europe.

"Stem Cells Market Will Reach $7.3 Billion in 2014," Visiongain Report PredictsLondon, United Kingdom, May 26, 2012 --(PR.com)-- That market will be stimulated by new treatments and increasing use of related products in drug development. Those findings appear in Stem Cell Technologies: World Market Outlook 2012-2022, published in May 2012. Visiongain is a business information provider based in London, UK. Visiongain forecasts that the stem cells market will expand rapidly...

Chemoradiotherapy has benefits for older lung cancer patientsAdding low-dose carboplatin to radiotherapy prolongs the survival of elderly people with non-small-cell lung cancer (NSCLC)

Telomere Stability And Carcinogenesis: An Off-Again, On-Again RelationshipPrevious studies in mice have demonstrated antagonistic effects of telomerase loss on carcinogenesis. Telomere attrition can promote genome instability thereby stimulating initiation of early-stage cancers, but can also inhibit tumorigenesis by promo...

Proteomic analysis of immunocamouflaged surfaces(Science in China Press) The immunocamouflage of cell surfaces by grafted polymers holds great potential in clinical medicine. In the current issue of Science China Life Sciences, researchers with the Canadian Blood Services have used proteomic analy...

City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem CellsCity of Hope was granted a $5,217,004 early translational research award by the California Institute for Regenerative Medicine (CIRM) to support the development of a T cell-based immunotherapy that re-directs a patient’s own immune response against glioma stem cells. City of Hope has been awarded more than $49.7 million in grant support from CIRM since a...

ODAC meeting to discuss RCC imagingFDA's Oncologic Drugs Advisory Committee (ODAC) will meet on July 25 to discuss the extent of useful clinical information provided by an imaging test for clear cell renal cell carcinoma (RCC) before surgery. FDA will also review the development strat...

CHMP recommends perampanel, aclidinium bromideEMA's CHMP issued several positive opinions on Friday, including one backing approval of Fycompa perampanel from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) to treat partial-onset seizures in epilepsy patients. The committee also supported approval of Br...

Cancer Imaging In Clear Cell Renal Carcinoma Gets ODAC Attention As Pipeline FillsFDA’s Oncologic Drugs Advisory Committee will examine the extent (if any) to which the pre-surgical identification of clear cell carcinoma of the kidney using an imaging test provides useful clinical information. ASCO abstracts show considerable re...

Skp2 activates cancer-promoting, glucose-processing AktHER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Pfizer says EU recommends approval of InlytaPfizer Inc. said Friday that European Union regulators are recommending approval for its kidney cancer drug Inlyta.A European Union advisory committee recommended that Inlyta be approved as a treatment for advanced renal cell carcinoma in patients w...

Xconomist of the Week: Evan Snyder—Stem Cell Reality CheckSan Diego Xconomist Evan Snyder has been called a “stem cell revolutionary” and is regarded as a father in the field of stem cell research. When we talked in his office at San Diego’s Sanford-Burnham Medical Research Institute, he told me he is...

Stem cell-growing surface enables bone repairUniversity of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.

Common therapies for basal cell carcinoma offer similar survival(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published online May 21 in the British Journal of...

ImmunoCellular to list on NYSE:MKTBiotech firm ImmunoCellular Therapeutics (OTC:IMUC) reported that its common stock will now be listed on the New York stock Exchange, as the company seeks a broader investor base.The California-based company develops novel therapies to fight against...

Special surface allows adult-derived stem cells to thrive and transform into multiple cell typesUniversity of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.

Researchers discover drug destroys human cancer stem cells but not healthy onesA team of scientists at McMaster has discovered that the drug thioridazine successfully kills cancer stem cells in humans while [...]

ImmunoCellular Therapeutics Receives Approval for NYSE MKT ListingImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that its common stock has been approved for listing on the NYSE: MKT. Trading is expected to commence on the NYSE: MKT on Wednesday, May 30th, 2012 under the...

Bone: An Endocrine Organ?Prior to 1964, bone was thought to be an inert, static storage depot for calcium crystal in the body. In that year, Dr. Harold Frost introduced the revolutionary hypothesis that bone was actually a very dynamic system that was constantly being remodeled in response to mechanical and gravitational stress. Today at the American Association of Clinical Endocr...

Emotions In Humans May Be Associated With Brain Cells Found In MonkeysA human's self-awareness is controlled by a small region in the brain called the anterior insular cortex (insula). Within the insula lies a unique cell type - the von Economo neuron (VEN) - believed to be unique to humans, elephants, whales and great...

New Drug For Destroying Human Cancer Stem CellsConventional cancer treatments, such as chemotherapy and radiation can cause toxic side-effects. Now, researchers have discovered that a drug called thioridazine can successfully destroy cancer stem cells in humans without these effects. Mick Bhatia,...

Vertex Pharma receives European recommendation for approval of cystic fibrosis drugVertex Pharmaceuticals (NASDAQ:VRTX) announced Friday that it has received the positive opinion of the European Committee for Medicinal Products for Human Use (CHMP), which recommended the approval of Kalydeco (ivacaftor) for cystic fibrosis. The com...

0 1 2 3 4 ›»

buy Stem Cell market research data and corporate reports now Advertisement